Tumor Necrosis Factor-α Antagonists Induce Lupus-like Syndrome in Patients with Scleroderma Overlap/Mixed Connective Tissue Disease [2]

Journal of Rheumatology

Volumn 30, Issue 12, 2003, Pages 2725-2727

  Christopher Stine, Lisa ^a   Wigley, Fredrick ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; DNA ANTIBODY; DOUBLE STRANDED DNA; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CHILL; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HUMAN; HYPOCOMPLEMENTEMIA; LETTER; LUPUS ERYTHEMATOSUS; MALE; MIXED CONNECTIVE TISSUE DISEASE; MYALGIA; NAUSEA; PAIN; PRIORITY JOURNAL; SCLERODERMA; SEROLOGY; SYNDROME DELINEATION; TREATMENT OUTCOME; VOMITING;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIXED CONNECTIVE TISSUE DISEASE; SCLERODERMA, SYSTEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0346218137     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Tutuncu Z, Morgan GJ Jr, Kavanaugh A. Anti-TNF therapy for other inflammatory conditions. Clin Exp Rheumatol 2002;206 Suppl 28:S146-51.
2. Fitzcharles MA, Clayton D, Menard HA. The use of infliximab in academic rheumatology practice: an audit of early clinical experience. J Rheumatol 2002:29:2525-30.
3. Charles PJ, Smeenk RJ, Delong J, Feldman M, Maini RN. Assessment of autoantibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000;43:283-90.
4. Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002;359:579-80.
5. DeBandt MJ, Descamps V, Meyer O. Two cases of etanercept-induced systemic lupus erythematosus in patients with rheumatoid arthritis [abstract]. Ann Rheum Dis 2001;60:175.
6. Gordon C, Ranges GE, Greenspan JS, Wofsky D. Chronic therapy with recombinant tumor necrosis factor in autoimmune NZB/NFI mice. Clin Immunol Immunopathol 1989;52:41-4.
7. Jacob CO, McDevitt HO. Tumor necrosis factor-alpha in murine autoimmune "lupus" nephritis. Nature 1988;331:356-8.
8. Aderka D, Wysenbeek A, Engelmann H, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993;36:1111-20.